Inactive Instrument

Rennova Health Inc Share Price Nasdaq

Equities

Duration

Period

Style

RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24/07/20	AQ
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	17/07/20	AQ
RENNOVA HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	08/07/20	AQ
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	29/06/20	AQ
RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	16/06/20	AQ

Managers	Title	Age	Since
Darrell Peterson CEO	Chief Executive Officer	65	13/05/23
Gerard Dab CHM	Chairman	75	13/05/23
Sebastien Sainsbury IRO	Public Communications Contact	61	-

Members of the board	Title	Age	Since
Gerard Dab CHM	Chairman	75	13/05/23
Sharon Hollis CEO	Chief Executive Officer	47	30/06/11
Francisco Roca BRD	Director/Board Member	58	13/05/23

Sector

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-15.34%	8.55B
RADNET, INC.	+64.74%	4.23B
DR. LAL PATHLABS LIMITED	+4.83%	2.68B
SYNLAB AG	-2.80%	2.61B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-54.53%	1.82B
NEOGENOMICS, INC.	-19.59%	1.66B
FLEURY S.A.	-21.51%	1.42B
METROPOLIS HEALTHCARE LIMITED	+15.98%	1.19B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-48.13%	1.05B